Sheffield Childrens NHS Foundation Trust

Sheffield S5 7AU

2 studies enrolling now · 16 studies all time

What they study most

Achondroplasia, Adenovirus Infection, Citrin Deficiency, Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS), Huntington Disease, Huntington's Disease, Osteogenesis Imperfecta, Respiratory Syncytial Virus (RSV), Tuberous Sclerosis Complex Associated Neuropsychiatric Disease, Urinary Bladder, Neurogenic

Studies at this site

• Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) — Recruiting now
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• Multi-omics Study in Citrin Deficiency — Running, not enrolling
• A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex — Completed
• An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia — Running, not enrolling
• An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia — Running, not enrolling
• Setrusumab vs Placebo for Osteogenesis Imperfecta — Running, not enrolling
• A Study to Evaluate EDP 938 Regimens in Children With RSV — Completed
• Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. — Stopped early
• A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia — Completed
• Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation — Stopped early
• A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia — Completed
• A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia — Completed
• A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition — Completed
• Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) — Stopped early
• Development of Assessments for Later Stage HD — Status unconfirmed